Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€127.35
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sarepta Therapeutics | 5.161% | 5.161% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sarepta Therapeutics diskutieren
Buy mit Kursziel 150,0
In the thread Trading Sarepta Therapeutics
Buy beendet